Vialinin AlipopolysaccharideARDSacute respiratory distress syndrome (ARDS)
…itment during inflammation. Targeting the USP4-IQGAP1 axis with Vialinin A represents a promising therapeutic strategy for patients with A…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,221–2,280 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
betablockers2biologic disease-modifying antirheumatic drugs2botensilimab2brivaracetam2calcium channel blocker2capsule sponge2carbon tetrachloride2ceftazidime-avibactam2cephalexin2chemo-IO2chlorpromazine2chondroitin sulfate2ciclesonide2ciltacabtagene autoleucel2cinacalcet2clodronate liposomes2clomipramine2colchicine-resistant2coumadin2covid vaccines2cross sex hormones2cyclosporine A2darunavir2deferasirox2deferoxamine2desvenlafaxine2dimercaprol2direct oral anticoagulant2docosahexaenoic acid2dolutegravir-based2drug-eluting stents2emergency medications2endothelin-receptor antagonists2eribulin2essential antibiotics2ferric derisomaltose2fibrates2fluoride2fluticasone furoate2fluticasone propionate2fomepizole2fonofos2fostamatinib2furazolidone2galantamine2garlic2glucagon-like peptide-1 (GLP-1) agonists2glucocorticoid-related2glycopeptides2glycoprotein IIb/IIIa2glycopyrronium bromide2hallucinogens2high caffeine2high dose steroids2high-dose statins2high-flow oxygen2hormone blockers2hydrocodone2hydroxyzine2hyoscine butylbromide2
Articles mentioning drugs
10,506 articles · page 395 of 876177Lu-PSMA-617androgen receptor pathway inhibitorspoly-ADP ribose polymerase (PARP) inhibitorsprostate cancermHSPCmCRPCchemotherapyhigh risk biochemical recurrence
…chemotherapy, poly-ADP ribose polymerase (PARP) inhibitors, and 177Lu-PSMA-617 in this disease space. Finally, as patients with prostate cance…
ketaminemood disordercardiomyopathyobstructive uropathycholangiopathyprogressive multisystem organ dysfunction
…stem organ dysfunction following 15 years of heavy recreational ketamine use. Complications included ketamine cystitis, cholangiopathy, …
tyrosine kinase inhibitorsimmune checkpoint inhibitorsanti-angiogenic agentschronic liver diseaseHepatocellular carcinomaHCCcirrhosis
…lt, sustained clinical responses to existing therapies, such as tyrosine kinase inhibitors, anti-angiogenic agents and immune checkpoint inhibitors, remai…
cisplatinmetastatic pancreatic ductal adenocarcinoma (PDAC)
…1high subtype that predicts early recurrence, poor survival and cisplatin resistance in PDAC. This subtype reveals new treatment vulnerab…
UpadacitinibSLE
…ation observed in our JAKi-activated subpopulations.Conclusions Upadacitinib was associated with enhanced platelet activation and procoagula…
GLP-1RAGLP-1 receptor agonistsPROSPEROgastroesophageal reflux diseaseGERD
…care, are enterally fed, or are taking GLP-1 receptor agonists (GLP-1RA). Study quality was assessed using the Mixed Methods Appraisal …
anifrolumabSLEDADA2systemic lupus erythematosussystemic vasculitis
…al diagnosis of DADA2. Strikingly, the patient was treated with anifrolumab (an anti-interferon alpha receptor 1 antibody) that rapidly ind…
UC-MSChuman allogenic UC-MSCCanadian Neonatal Intensive Care UnitsBronchopulmonary dysplasiaOttawa Health Science Network Research Ethics BoardELGABPD
…l be randomised to receive either 3 weekly intravenous doses of UC-MSC (10×10 6 cells/kg/dose) or a sham procedure. The primary outcom…
colchicineFamilial Mediterranean fever (FMF)
…t homozygous patients with severe disease requiring higher-dose colchicine and IL-1 inhibitors. Not all heterozygous patients had a mild d…
intravenous fentanylintravenous opioidsintravenous morphinesevere pain
…k aimed to describe national nurse-led intravenous morphine and intravenous fentanyl administration in adult type 1 EDs.…
infliximabIntravenous corticosteroidsJanus kinase inhibitorsulcerative colitisadjunct therapiesASUCsequential salvage strategies
…-responders and in particular the timing and dosing schedule of infliximab.In addition, we explore other approaches including use of Janus…